Home/Filings/4/0001209191-23-018046
4//SEC Filing

Treace John T. 4

Accession 0001209191-23-018046

CIK 0001630627other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 9:00 PM ET

Size

13.1 KB

Accession

0001209191-23-018046

Insider Transaction Report

Form 4
Period: 2023-03-09
Treace John T.
DirectorChief Executive Officer10% Owner
Transactions
  • Sale

    Common Stock

    2023-03-09$24.41/sh2,075$50,6515,539,380 total
  • Award

    Common Stock

    2023-03-10+82,4755,621,855 total
  • Award

    Stock Option (Right to Buy)

    2023-03-10+186,900186,900 total
    Exercise: $24.07Exp: 2033-03-10Stock Option (Right to Buy) (186,900 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    1,839,063
  • Common Stock

    (indirect: By Trust)
    408,816
  • Common Stock

    (indirect: By Spouse)
    1,605,000
  • Common Stock

    (indirect: By Trust)
    1,471,250
Footnotes (7)
  • [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F2]Includes 25,406 restricted stock units.
  • [F3]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
  • [F4]Includes 107,881 RSUs.
  • [F5]The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
  • [F6]The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.
  • [F7]The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001856380

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 9:00 PM ET
Size
13.1 KB